B cells shape T follicular helper differentiation by acting as specialised antigen-presenting cells that deliver both peptide-MHC signals and critical co-stimulation to naïve CD4 T cells. Antigen presentation by B cells is initiated when the B cell receptor captures cognate antigen, processes it and displays peptides on MHC class II for recognition by T cell receptors. Shane Crotty at La Jolla Institute for Immunology explains that this intimate B–T interaction concentrates help where B cells have already selected specific antigen, promoting the emergence of T cells that support antibody maturation. This is not simply a one-way delivery of peptide; it is an instructive synapse that tunes T cell fate.
Mechanisms: how B cells instruct Tfh
Effective T follicular helper differentiation requires more than peptide recognition. Engagement of co-stimulatory pathways such as ICOS-ICOSL and CD40-CD40L and the expression of co-inhibitory and accessory molecules by B cells influence whether a CD4 T cell upregulates the transcription factor Bcl6 and acquires the Tfh program. Rafi Ahmed at Emory University has described how sustained antigen presentation and repeated contact with antigen-bearing B cells support maintenance of Bcl6 expression and migration into B cell follicles. Cytokines in the microenvironment, including IL-6 and IL-21, amplify this differentiation in a context-dependent manner. The affinity of the initial B cell receptor and the density of peptide-MHC on the B cell surface therefore bias the likelihood that a cooperating CD4 T cell will become a durable Tfh cell.
Relevance, causes, and consequences
When B cells effectively present antigen, the resulting pool of T follicular helper cells promotes germinal center formation, somatic hypermutation and high-affinity antibody production, processes essential for vaccine efficacy and durable humoral immunity. Conversely, insufficient or aberrant antigen presentation can impair vaccine responses or contribute to autoimmunity by supporting Tfh that help self-reactive B cells. Environmental and territorial factors such as chronic infections and nutritional stress can reshape B cell function and thereby alter Tfh differentiation, affecting public health outcomes in regions with high burdens of malaria or HIV where Tfh responses are frequently perturbed. Understanding the B cell–Tfh axis is therefore central to rational vaccine design and to therapies aimed at modulating harmful antibody responses, as emphasized by experts like Shane Crotty at La Jolla Institute for Immunology and Rafi Ahmed at Emory University. The balance of antigen presentation, co-stimulation and cytokine milieu ultimately determines whether help is protective or pathological.